INVESTOR AB — BIOMARIN PHARMACEUTICALS BMRN: Quarterly 13F Position History
INVESTOR AB has reported BIOMARIN PHARMACEUTICALS (BMRN) on 5 13F-HR filings in Pactolio's tracked window, first appearing in Q1 2025. As of Q1 2026, the position is sized at 3,700 shares ($209.0K market value, 0.00% of the equity book).
- 3,700Shares Held (Latest Filing)
- $209.0KReported Market Value (Latest Filing)
- 0.00%Portfolio Weight (% of 13F Equity Book)
- 0Quarter-over-Quarter Share Change
- -$10.9KQuarter-over-Quarter Value Change
- 3,700Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 5 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 3,700 | 0 | — | $209.0K | 0.00% | $56.49 |
| Q4 2025 | 3,700 | 0 | — | $219.9K | 0.00% | $59.43 |
| Q3 2025 | 3,700 | 0 | — | $200.4K | 0.00% | $54.16 |
| Q2 2025 | 3,700 | 0 | — | $203.4K | 0.00% | $54.97 |
| Q1 2025 | 3,700 | — | — | $261.6K | 0.01% | $70.69 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did INVESTOR AB first disclose a BMRN position in 13F-HR filings?
INVESTOR AB first reported BIOMARIN PHARMACEUTICALS (BMRN) on its 13F-HR filing for the period ending 2025-03-31 (Q1 2025). The position has appeared on 5 reported quarters within Pactolio's tracked window.
What was INVESTOR AB's most recent quarter-over-quarter share-count change in BMRN?
INVESTOR AB held the same 3,700 shares of BMRN between Q4 2025 and Q1 2026 — the reported share count was unchanged quarter-over-quarter.
Does the implied price-per-share represent INVESTOR AB's cost basis in BMRN?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.